Showing results (21-30 of 176) with videos related to
Sort By:
Pageof 18
Biochemistry|August 8, 2025
Effects of Membrane Cholesterol on the Structure and Function of Selected Class A GPCRs─Challenges and Future PerspectivesMarina Christofidi, Efpraxia Tzortzini, Thomas Mavromoustakos, et al.Methods in Molecular Biology (Clifton, N.J.)|October 28, 2020
Unveiling the Thermodynamic Aspects of Drug-Cyclodextrin Interactions Through Isothermal Titration CalorimetryMaria V Chatziathanasiadou, Thomas Mavromoustakos, Andreas G TzakosChemmedchem|March 3, 2026
Advancing Accurate Quantification of Protein-Ligand Interactions: Differential Scanning Calorimetry as a Precision Screening Tool Using BCL-2 as a Model SystemBircan Dinc, Berna Dogan, Thomas Mavromoustakos, et al.Methods in Molecular Biology (Clifton, N.J.)|March 24, 2021
Ligand-Receptor Interactions and Drug DesignAggeliki Syriopoulou, Ioannis Markopoulos, Andreas G Tzakos, et al.Journal of Pharmaceutical and Biomedical Analysis|February 28, 2002
Structure elucidation and conformational properties of eprosartan, a non peptide angiotensin II AT1 antagonistPanagiotis Zoumpoulakis, Simona Golic Grdadolnik, John Matsoukas, et al.Bioorganic & Medicinal Chemistry|July 4, 2008
Comparative molecular dynamics simulations of the potent synthetic classical cannabinoid ligand AMG3 in solution and at binding site of the CB1 and CB2 receptorsSerdar Durdagi, Heribert Reis, Manthos G Papadopoulos, et al.Journal of Chemical Theory and Computation|November 21, 2015
A Comparative Molecular Dynamics, MM-PBSA and Thermodynamic Integration Study of Saquinavir Complexes with Wild-Type HIV-1 PR and L10I, G48V, L63P, A71V, G73S, V82A and I84V Single MutantsHaralambos Tzoupis, Georgios Leonis, Thomas Mavromoustakos, et al.Biomedicines|June 26, 2026
Targeting the Crosstalk Between Metabolism and Chronic Inflammation: In Silico Multitargeting Drug Design Approach for Cardiometabolic SyndromeErrikos Petsas, Gerasimos Siasos, Thomas Mavromoustakos, et al.Bioorganic & Medicinal Chemistry|November 11, 2008
Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulationsSerdar Durdagi, Thomas Mavromoustakos, Nikos Chronakis, et al.Bioorganic & Medicinal Chemistry Letters|November 6, 2007
Combined 3D QSAR and molecular docking studies to reveal novel cannabinoid ligands with optimum binding activitySerdar Durdagi, Manthos G Papadopoulos, Demetris P Papahatjis, et al.Pageof 18